BioNTech SE (BNTX) Minority Interest (2018)
BioNTech SE (BNTX) posted Minority Interest of $966762.8 for Q4 2018.
BioNTech SE (BNTX) Minority Interest (2018) Analysis & Trends
BioNTech SE has reported Minority Interest for 1 years, with the latest figure at $966762.8 in Q4 2018.
- Quarterly Minority Interest changed N/A year-over-year to $966762.8 in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $966762.8 (changed N/A YoY) and the FY2018 annual result came in at $1.0 million, changed N/A from the prior year.
- Minority Interest was little changed at $966762.8 in Q4 2018 per BNTX's latest filing.
- Over five years, Minority Interest peaked at $966762.8 in Q4 2018 and troughed at $966762.8 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.87 Bn | 78.87 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.40 Bn | 60.22 Bn | 1.37 Bn |
| 4 | Moderna | 59.36 Bn | 54.22 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.91 Bn | 28.60 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.17 Bn | 9.78 Bn | 668.28 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Roivant Sciences | 26.42 Bn | 26.42 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 966,762.77 |